Registered Owners
- View profile →
LAPI LABORATORIES - INDONESIA
KAB. SERANG
NPWP: 12345678910
owner
Direktorat Registrasi ObatValid
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE
- BPOM Number
- GKL2513327715B1
- Approved
- 18 November 2025
- Expiry
- 17 November 2030
- Form
- TABLET SALUT ENTERIK
About This Registration
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2513327715B1. Its current registration status is Valid, with the licence valid until 17 November 2030. The product is registered to LAPI LABORATORIES - INDONESIA. BPOM first approved this registration in November 2025. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration Details
- Application
- newaero
- Packaging
- DUS, 2 BLISTER @ 10 TABLET SALUT ENTERIK
- Department
- Direktorat Registrasi Obat
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
LAPI LABORATORIES - INDONESIA
KAB. SERANG
primary
Ingredients (1)
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE
Market Intelligence
- Owner Portfolio
- LAPI LABORATORIES - INDONESIA holds 246 BPOM registrations
- Manufacturer Scale
- LAPI LABORATORIES - INDONESIA produces 246 registered products
- Registration Age
- Registered for 9 months
FDA Cross-Reference
via openFDA- Generic Name
- ESOMEPRAZOLE MAGNESIUM
- Product Type
- HUMAN PRESCRIPTION DRUG
- Route of Administration
- ORAL
Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.
More products from LAPI LABORATORIES - INDONESIA
Products in the same class
AFIBRAMOL FORTE
-DBL2601712904A1
Approved: Apr 10, 2026KAPLET
AFIFARMA - INDONESIA